Fibrates Therapy
Fibrates Therapy is a pharmacological treatment modality that belongs to the class of lipid-lowering interventions and is distinguished by the use of peroxisome proliferator-activated receptor alpha (PPAR-α) agonists to modulate immune and metabolic pathways in the management of autoimmune liver diseases.
90
Publications
4.9K
Citations
513
Authors
221
Institutions
Publications per year
2017–2026
17
Variants
Fibrate Therapy
90
Ngoc Vu‐Dac, Philippe Gervois, Heidi Jakel et al. · Journal of Biological Chemistry · 2003 · 208 citations · Full text
Philippe Gervois, Ngoc Vu‐Dac, Robert Kleemann et al. · Journal of Biological Chemistry · 2001 · 153 citations · Full text
1–5 of 90
513
12
h-index
6
h-index
6
h-index
Netherlands Organisation for Applied Scientific Research, Netherlands
5 publications · 399 citations
5
h-index
4
h-index
1–5 of 513
221
Inserm
Paris, France
12 h-index
14 publications
1.4K citations

Institut Pasteur de Lille
Lille, France
10 h-index
10 publications
1.2K citations
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Bologna, Italy
3 h-index
3 publications
114 citations
Shinshu University
Matsumoto, Japan
3 h-index
3 publications
73 citations
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Barcelona, Spain
3 h-index
3 publications
285 citations
Université de Lille
Lille, France
3 h-index
3 publications
332 citations
National Cancer Institute
Bethesda, United States
3 h-index
3 publications
179 citations
Universitat de Barcelona
Barcelona, Spain
3 h-index
3 publications
285 citations
1–8 of 221
Repository · 9 publications · 241 citations
9
h-index
JBC · 5 publications · 622 citations
5
h-index
JLR · 3 publications · 263 citations
3
h-index
3 publications · 211 citations
3
h-index
3 publications · 82 citations
3
h-index
1–5